In a recent development, U.S. District Chief Judge F. Dennis Saylor IV in Massachusetts has ruled in favor of Insulet Corp., granting their motion for post-verdict discovery. This decision allows Insulet Corp. to obtain financial records from the defendants following a $59.4 million judgment in a trade secrets dispute. The case focuses on an insulin patch pump designed by Insulet, with the company alleging that various EOFlow entities and Nephria Bio, along with an executive officer, misappropriated trade secrets related to the product.
The defendants contested Insulet’s motion to compel the discovery of financial documents, arguing that it was both premature and overly broad. However, the court’s decision now enables Insulet to scrutinize the financial standing of the defendants, crucial in assessing their capacity to satisfy the judgment. For further details, consider reading the full report here.